
Quantum-Si (QSI) Stock Forecast & Price Target
Quantum-Si (QSI) Analyst Ratings
Bulls say
Quantum-Si Inc is projected to grow its revenues from $6.8 million in 2026 to $139.4 million in 2030, highlighting significant potential in the proteomics market. The company's strategic distribution agreement with Avantor and partnerships with 15 international distribution firms are expected to enhance the reach of its products across various sectors, including government and pharmaceutical markets. Furthermore, ongoing advancements in the Proteus platform, characterized by rapid sequencing capabilities and increased sample throughput, position Quantum-Si for sustained innovation and long-term growth in protein sequencing applications.
Bears say
Quantum-Si Inc has reportedly experienced significant losses related to its marketable securities, indicating potential volatility in its financial position. Additionally, the company is facing challenges in gaining market traction for its proprietary Next-Generation Protein Sequencing platform, which could hinder revenue growth. These factors, combined with ongoing operational expenses, contribute to a negative outlook on the company's stock performance.
This aggregate rating is based on analysts' research of Quantum-Si and is not a guaranteed prediction by Public.com or investment advice.
Quantum-Si (QSI) Analyst Forecast & Price Prediction
Start investing in Quantum-Si (QSI)
Order type
Buy in
Order amount
Est. shares
0 shares